The first therapy specifically indicated for chronic hand eczema (CHE) has passed muster at the FDA.

BALLERUP, Denmark I July 23, 2025 I LEO Pharma, a global leader in medical dermatology, announced today that the U.S. Food and Drug Administration (FDA) has ...

And TYK2, it has to be remembered is a JAK. So, we're all waiting to see to what extent the TYK2 JAK will be able to give us comparable efficacy in psoriatic arthritis, perhaps with reduced toxicity.

Support for providing immigrants living in the country illegally with a pathway to legal status in the U.S. has increased over the past six months, according to a new Quinnipiac University poll. In… ...

Who Is Jak Malone? Get to Know the Tony-Winning Breakout Star from Broadway’s Operation Mincemeat News by Alexandra Pierson • Jun 8, 2025 Jak Malone (Photo by Sergio Villarini for Broadway.com) ...

BHV-8000 is a first-in-clinic, brain-penetrant, and selective inhibitor of TYK2 and JAK1 kinases — a novel investigational therapy with the potential to treat the neuroinflammation and immune ...

AC-201, a selective TYK2/JAK1 inhibitor with therapeutic potential across a broad range of immune mediated inflammatory diseases, has completed a phase 2 clinical trial in Psoriasis with first ...

AC-201, a selective TYK2/JAK1 inhibitor with therapeutic potential across a broad range of immune mediated inflammatory diseases, has completed a phase 2 clinical trial in Psoriasis with first-rate ...